In this panel discussion, Dr. Steven Frank exchanges views on the best ways to de-risk your proton therapy project with five experts from the proton therapy community, involved in financing, developing and managing proton therapy facilities. They talk about vision, market, model, financing, and strategy. Watch the panel's recording now and discover their answers to the following questions:

• (08:00) Are protons a nice-to-have or a must-have and why does that matter? 
• (18:00) What is the cost of not having a proton therapy facility? What is the HALO effect of a proton center, why is it important, and how to measure and communicate it? 
• (28:45) How to define the appropriate market, at the level of the institution, region, country and internationally? How to take into account the disease mix, patient demographics, reimbursement, payor mix and tax exemptions when analyzing the financial success of a proton therapy center?
• (40:40) What is the realistic vision when modeling the cash flow opportunity around proton therapy? How to recognize the factors that could lead to failure?
• (56:20) What is the importance of the balance sheet for the potential sponsor of a center, and for the center itself? How are risks shared among stakeholders?
• (1:15:45) How often should volumetric strategies be adjusted? How to manage the patient volume strategy? How should research fit into a center’s strategy?

The invited panelists conclude on the importance of partnership and collective teamwork to develop a successful proton therapy center, with an adequate financing structure, that ultimately improves the access of patients to proton therapy.